Literature DB >> 7362811

Autosomal dominant exudative vitreoretinopathy.

R R Ober, A C Bird, A M Hamilton, K Sehmi.   

Abstract

Twelve affected members from 3 families with autosomal dominant exudative vitreouretinopathy were examined, and the following conclusions were drawn: (1) There is great variability in the phenotypic expression of the abnormal gene, such that many patients have very mild disease which can be detected with certainty only by fluorescein angiography. (2) Gene penetrance is close to 100%. (3) Progress of fundus changes and visual threat is rare after 20 years of age.

Entities:  

Mesh:

Year:  1980        PMID: 7362811      PMCID: PMC1039360          DOI: 10.1136/bjo.64.2.112

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  9 in total

1.  CLINICAL EVALUATION OF SCHOOL-AGE CHILDREN WITH RETROLENTAL FIBROPLASIA.

Authors:  J COHEN; J E ALFANO; L D BOSHES; C PALMGREN
Journal:  Am J Ophthalmol       Date:  1964-01       Impact factor: 5.258

2.  Fluorescein angiographic findings in familial exudative vitreoretinopathy.

Authors:  C L Canny; G L Oliver
Journal:  Arch Ophthalmol       Date:  1976-07

3.  Retrolental fibroplasia: clinical, fluorescein angiographic and pathological correlation.

Authors:  G E O'Grady; J T Flynn; J Clarkson; R D Clark
Journal:  Mod Probl Ophthalmol       Date:  1974

4.  Wagner's hereditary vitreoretinal degeneration and retinal detachment.

Authors:  T Hirose; K Y Lee; C L Schepens
Journal:  Arch Ophthalmol       Date:  1973-03

5.  Ophthalmoscopic monitoring of oxygen therapy in premature infants. Fluorescein angiography in acute retrolental fibroplasia.

Authors:  S J Cantolino; G E O'Grady; J A Herrera; C Israel; J Justice; J T Flynn
Journal:  Am J Ophthalmol       Date:  1971-08       Impact factor: 5.258

6.  Familial exudative vitreoretinopathy.

Authors:  V G Criswick; C L Schepens
Journal:  Am J Ophthalmol       Date:  1969-10       Impact factor: 5.258

7.  Familial exudative vitreoretinopathy. An expanded view.

Authors:  J Gow; G L Oliver
Journal:  Arch Ophthalmol       Date:  1971-08

8.  Dominantly inherited peripheral retinal neovascularization.

Authors:  K A Gitter; H Rothschild; D D Waltman; B Scott; P Azar
Journal:  Arch Ophthalmol       Date:  1978-09

9.  Retrolental fibroplasia: I. Clinical observations.

Authors:  J T Flynn; G E O'Grady; J Herrera; B J Kushner; S Cantolino; W Milam
Journal:  Arch Ophthalmol       Date:  1977-02
  9 in total
  28 in total

1.  [Criswick-Schepens syndrome -- familial exudative vitreoretinopathy. Report of six cases in two consanguineous families].

Authors:  A Alsheikheh; W Lieb; F Grehn
Journal:  Ophthalmologe       Date:  2004-09       Impact factor: 1.059

2.  [Familial exudative vitreoretinopathy].

Authors:  D Finis; J Stammen; A M Joussen
Journal:  Ophthalmologe       Date:  2010-07       Impact factor: 1.059

3.  Reduced bone mineral density and hyaloid vasculature remnants in a consanguineous recessive FEVR family with a mutation in LRP5.

Authors:  L M Downey; H M Bottomley; E Sheridan; M Ahmed; D F Gilmour; C F Inglehearn; A Reddy; A Agrawal; J Bradbury; C Toomes
Journal:  Br J Ophthalmol       Date:  2006-09       Impact factor: 4.638

4.  [Mutations of the frizzled-4 gene. Their impact on medical care of patients with autosomal dominant exudative vitreoretinopathy].

Authors:  M Müller; C Kusserow; U Orth; U Klär-Dissars; H Laqua; A Gal
Journal:  Ophthalmologe       Date:  2008-03       Impact factor: 1.059

5.  Dominant exudative vitreoretinopathy and other vascular developmental disorders of the peripheral retina.

Authors:  C E van Nouhuys
Journal:  Doc Ophthalmol       Date:  1982-09-23       Impact factor: 2.379

6.  Visual loss from retinal oedema in autosomal dominant exudative vitreoretinopathy.

Authors:  D Swanson; P Rush; A C Bird
Journal:  Br J Ophthalmol       Date:  1982-10       Impact factor: 4.638

7.  Further evidence of genetic heterogeneity in familial exudative vitreoretinopathy; exclusion of EVR1, EVR3, and EVR4 in a large autosomal dominant pedigree.

Authors:  C Toomes; L M Downey; H M Bottomley; H A Mintz-Hittner; C F Inglehearn
Journal:  Br J Ophthalmol       Date:  2005-02       Impact factor: 4.638

8.  Familial exudative vitreoretinopathy.

Authors:  W E Benson
Journal:  Trans Am Ophthalmol Soc       Date:  1995

9.  Congenital retinal fold as a sign of dominant exudative vitreoretinopathy.

Authors:  C E van Nouhuys
Journal:  Albrecht Von Graefes Arch Klin Exp Ophthalmol       Date:  1981

10.  X linked exudative vitreoretinopathy: clinical features and genetic linkage analysis.

Authors:  P Fullwood; J Jones; S Bundey; J Dudgeon; A R Fielder; M W Kilpatrick
Journal:  Br J Ophthalmol       Date:  1993-03       Impact factor: 4.638

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.